Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Synthesis and pharmacological evaluation of indolinone derivatives as novel ghrelin receptor antagonists.

Puleo L, Marini P, Avallone R, Zanchet M, Bandiera S, Baroni M, Croci T.

Bioorg Med Chem. 2012 Sep 15;20(18):5623-36. doi: 10.1016/j.bmc.2012.07.018. Epub 2012 Jul 24.

PMID:
22901671
2.

Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated corpora cavernosa.

Guagnini F, Ferazzini M, Grasso M, Blanco S, Croci T.

J Transl Med. 2012 Mar 23;10:59. doi: 10.1186/1479-5876-10-59.

3.

GPR40 is partially required for insulin secretion following activation of beta3-adrenergic receptors.

Pang Z, Wu N, Zhang X, Avallone R, Croci T, Dressler H, Palejwala V, Ferrara P, Tocci MJ, Polites HG.

Mol Cell Endocrinol. 2010 Aug 30;325(1-2):18-25. doi: 10.1016/j.mce.2010.04.014. Epub 2010 Apr 21.

PMID:
20416356
4.

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia.

Caraceni P, Pertosa AM, Giannone F, Domenicali M, Grattagliano I, Principe A, Mastroleo C, Perrelli MG, Cutrin J, Trevisani F, Croci T, Bernardi M.

Gut. 2009 Aug;58(8):1135-43. doi: 10.1136/gut.2007.147652. Epub 2009 Mar 11.

PMID:
19282305
5.

Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.

Domenicali M, Caraceni P, Giannone F, Pertosa AM, Principe A, Zambruni A, Trevisani F, Croci T, Bernardi M.

Gastroenterology. 2009 Jul;137(1):341-9. doi: 10.1053/j.gastro.2009.01.004. Epub 2009 Jan 14.

PMID:
19208344
6.

The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats.

Vasina V, Abu-Gharbieh E, Barbara G, de Giorgio R, Colucci R, Blandizzi C, Bernardini N, Croci T, Del Tacca M, de Ponti F.

Neurogastroenterol Motil. 2008 Sep;20(9):1030-41. doi: 10.1111/j.1365-2982.2008.01138.x. Epub 2008 May 15.

PMID:
18492028
7.

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.

Gary-Bobo M, Elachouri G, Gallas JF, Janiak P, Marini P, Ravinet-Trillou C, Chabbert M, Cruccioli N, Pfersdorff C, Roque C, Arnone M, Croci T, Soubrié P, Oury-Donat F, Maffrand JP, Scatton B, Lacheretz F, Le Fur G, Herbert JM, Bensaid M.

Hepatology. 2007 Jul;46(1):122-9.

PMID:
17526015
8.

In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.

Croci T, Cecchi R, Marini P, Rouget C, Viviani N, Germain G, Guagnini F, Fradin Y, Descamps L, Pascal M, Advenier C, Breuiller-Fouché M, Leroy MJ, Bardou M.

J Pharmacol Exp Ther. 2007 Jun;321(3):1118-26. Epub 2007 Mar 9.

PMID:
17351104
10.

Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.

Guagnini F, Cogliati P, Mukenge S, Ferla G, Croci T.

Br J Pharmacol. 2006 Aug;148(8):1165-73. Epub 2006 Jun 19.

11.

Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.

Guagnini F, Valenti M, Mukenge S, Matias I, Bianchetti A, Di Palo S, Ferla G, Di Marzo V, Croci T.

Gut. 2006 Jul;55(7):946-53. Epub 2006 Jan 19.

12.
13.

Beta3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy.

Rouget C, Bardou M, Breuiller-Fouché M, Loustalot C, Qi H, Naline E, Croci T, Cabrol D, Advenier C, Leroy MJ.

J Clin Endocrinol Metab. 2005 Mar;90(3):1644-50. Epub 2004 Dec 7.

PMID:
15585565
14.

The human near-term myometrial beta 3-adrenoceptor but not the beta 2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation.

Rouget C, Breuiller-Fouché M, Mercier FJ, Leroy MJ, Loustalot C, Naline E, Frydman R, Croci T, Morcillo EJ, Advenier C, Bardou M.

Br J Pharmacol. 2004 Mar;141(5):831-41. Epub 2004 Feb 9.

15.

SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.

Gougat J, Ferrari B, Sarran L, Planchenault C, Poncelet M, Maruani J, Alonso R, Cudennec A, Croci T, Guagnini F, Urban-Szabo K, Martinolle JP, Soubrié P, Finance O, Le Fur G.

J Pharmacol Exp Ther. 2004 May;309(2):661-9. Epub 2004 Jan 27.

PMID:
14747609
16.
17.

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.

Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L.

Eur J Pharmacol. 2002 Aug 16;450(1):77-83.

PMID:
12176112
18.

Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon.

Manara L, Croci T, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G.

Dig Liver Dis. 2002 Apr;34(4):262-9.

PMID:
12038810
19.

Intestinal motor stimulation by the 5-HT4 receptor agonist ML10302: differential involvement of tachykininergic pathways in the canine small bowel and colon.

De Ponti F, Crema F, Moro E, Nardelli G, Croci T, Frigo GM.

Neurogastroenterol Motil. 2001 Dec;13(6):543-53.

PMID:
11903915
20.

[Inhibition of uterine contractions: new in vitro pharmacological approaches on the pregnant human myometrium].

Bardou M, Loustalot C, Simon B, Morcillo E, Croci T, Advenier C.

Therapie. 2001 May-Jun;56(3):213-22. French.

PMID:
11475797
21.

Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium.

Bardou M, Loustalot C, Cortijo J, Simon B, Naline E, Dumas M, Esteve S, Croci T, Chalon P, Frydman R, Sagot P, Manara L, Morcillo EJ, Advenier C.

Br J Pharmacol. 2000 Aug;130(8):1960-6.

22.

Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle.

Manara L, Croci T, Aureggi G, Guagnini F, Maffrand JP, Le Fur G, Mukenge S, Ferla G.

Gut. 2000 Sep;47(3):337-42.

23.

In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips.

Croci T, Aureggi G, Guagnini F, Manara L, Gully D, Fur GL, Maffrand JP, Mukenge S, Ferla G, Ferrara P, Chalon P, Vita N.

Br J Pharmacol. 1999 Aug;127(8):1922-8.

24.
25.

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum.

Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G.

Br J Pharmacol. 1998 Dec;125(7):1393-5.

26.

In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a beta3-adrenoceptor-mediated effect.

Bardou M, Dousset B, Deneux-Tharaux C, Smadja C, Naline E, Chaput JC, Naveau S, Manara L, Croci T, Advenier C.

Eur J Pharmacol. 1998 Jul 24;353(2-3):281-7.

PMID:
9726658
27.

In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.

Croci T, Aureggi G, Manara L, Emonds-Alt X, Le Fur G, Maffrand JP, Mukenge S, Ferla G.

Br J Pharmacol. 1998 Jul;124(6):1321-7.

28.

Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist.

Emonds-Alt X, Advenier C, Cognon C, Croci T, Daoui S, Ducoux JP, Landi M, Naline E, Neliat G, Poncelet M, Proietto V, Van Broeck D, Vilain P, Soubrié P, Le Fur G, Maffrand JP, Brelière JC.

Neuropeptides. 1997 Oct;31(5):449-58.

PMID:
9413022
29.

Role of tachykinins in castor oil diarrhoea in rats.

Croci T, Landi M, Emonds-Alt X, Le Fur G, Maffrand JP, Manara L.

Br J Pharmacol. 1997 Jun;121(3):375-80.

30.

Arylcarbamate derivatives of 1-piperidineethanol as potent ligands for 5-HT4 receptors.

Soulier JL, Yang D, Brémont B, Croci T, Guzzi U, Langlois M.

J Med Chem. 1997 May 23;40(11):1755-61.

PMID:
9171886
31.

Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.

Croci T, Landi M, Gully D, Maffrand JP, Le Fur G, Manara L.

Br J Pharmacol. 1997 Apr;120(7):1312-8.

32.

New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.

Yang D, Soulier JL, Sicsic S, Mathé-Allainmat M, Brémont B, Croci T, Cardamone R, Aureggi G, Langlois M.

J Med Chem. 1997 Feb 14;40(4):608-21.

PMID:
9046352
33.

Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A.

De Ponti F, Gibelli G, Croci T, Arcidiaco M, Crema F, Manara L.

Br J Pharmacol. 1996 Apr;117(7):1374-6.

34.

Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.

Manara L, Badone D, Baroni M, Boccardi G, Cecchi R, Croci T, Giudice A, Guzzi U, Landi M, Le Fur G.

Br J Pharmacol. 1996 Feb;117(3):435-442.

35.

The non-peptide tachykinin NK1- and NK2-receptor antagonists SR 140333 and SR 48968 prevent castor-oil induced diarrhea in rats.

Croci T, Emonds-Alt X, Le Fur G, Maffrand JP, Manara L.

Acta Physiol Hung. 1996;84(3):273-4.

PMID:
9219603
36.

Promotion by SR 48692 of gastric emptying and defaecation in rats suggesting a role of endogenous neurotensin.

Croci T, Giudice A, Manara L, Gully D, Le Fur G.

Br J Pharmacol. 1995 Jun;115(3):383-4.

37.

Drug-induced defaecation in rats: role of central 5-HT1A receptors.

Croci T, Landi M, Bianchetti A, Manara L.

Br J Pharmacol. 1995 May;115(1):203-9.

38.

Beta 3-adrenoceptors and intestinal motility.

Manara L, Croci T, Landi M.

Fundam Clin Pharmacol. 1995;9(4):332-42. Review.

PMID:
8566932
40.

Neuronal NK3-receptors in guinea-pig ileum and taenia caeci: in vitro characterization by their first non-peptide antagonist, SR142801.

Croci T, Landi M, Emonds-Alt X, Le Fur G, Manara L.

Life Sci. 1995;57(23):PL361-6. No abstract available.

PMID:
7475959
41.

Manometric patterns of rat colonic motor activity and defecation. Effect of selective 5HT1A agonist 8-OH-DPAT.

Croci T, Basilisco G, Bassani A, Manara L.

Dig Dis Sci. 1994 Sep;39(9):1968-73.

PMID:
8082505
42.

SR 48968 selectively prevents faecal excretion following activation of tachykinin NK2 receptors in rats.

Croci T, Emonds-Alt X, Manara L.

J Pharm Pharmacol. 1994 May;46(5):383-5.

PMID:
8083813
43.

SR 48968, a neurokinin A (NK2) receptor antagonist.

Emonds-Alt X, Advenier C, Croci T, Manara L, Neliat G, Poncelet M, Proietto V, Santucci V, Soubrié P, Van Broeck D, et al.

Regul Pept. 1993 Jul 2;46(1-2):31-6. Review. No abstract available.

PMID:
8210494
44.
45.
46.

Stimulation of faecal excretion in rats by alpha 2-adrenergic antagonists.

Croci T, Bianchetti A.

J Pharm Pharmacol. 1992 Apr;44(4):358-60.

PMID:
1355551
47.
48.

Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents.

Croci T, Cecchi R, Tarantino A, Aureggi G, Bianchetti A, Boigegrain R, Manara L.

Pharmacol Res Commun. 1988 Feb;20(2):147-51.

PMID:
2898155
49.
50.

Prevention of TCDD toxicity in laboratory rodents by addition of charcoal or cholic acids to chow.

Manara L, Coccia P, Croci T.

Food Chem Toxicol. 1984 Oct;22(10):815-8.

PMID:
6541620

Supplemental Content

Support Center